Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
23
24
25
26
27
28
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Press Releases

Lord’s Mark Sends First $1M MedTech Shipment to U.S

Mumbai, India (NewsVoir)
Lord’s Mark Industries Limited, one of India’s fastest-growing diversified business groups, has announced the successful execution and shipment of its first MedTech order to the United States, valued at USD 1 million. This milestone, achieved through Lord’s Mark Industries Ltd., marks a significant step in the company’s global expansion and highlights India’s increasing prominence in advanced healthcare technology exports.

The shipment includes next-generation Contactless Remote Patient Monitoring (RPM) and AI-powered Early Warning Systems (EWS) — innovative healthcare solutions conceptualized, designed, and manufactured entirely in India. These technologies integrate real-time patient monitoring, predictive analytics, and Electronic Health Record (EHR) systems to deliver proactive, data-driven clinical care.

“This achievement underscores India’s emergence as a hub for world-class MedTech innovation,” said Sachidanand Upadhyay, Managing Director of Lord’s Mark Industries Ltd. “Our first U.S. shipment is not just an export—it signifies the global rise of India’s MedTech capabilities. We are developing healthcare technologies that meet the world’s highest standards, establishing Lord’s Mark Industries Ltd. as a global player and Indian innovation as a trusted benchmark in international markets.”

Lord’s Mark Industries Ltd. operates through key subsidiaries, including LordsMed, Lord’s Mark Biotech Pvt. Ltd., and Lords Mark Microbiotech Pvt. Ltd. With a steadfast commitment to innovation and excellence, the company continues to expand while maintaining the highest quality standards. Diversification remains the cornerstone of Lord’s Mark Industries’ long-term growth and success.

Founded in 1998, Lord’s Mark Industries Ltd. has evolved into a leading force in the healthcare and diagnostics industry. Leveraging a legacy of innovation, the company has strategically diversified into medical diagnostics, pharmaceuticals, and genome testing—strengthening its presence across the entire healthcare value chain.

For more information, visit www.lordsmark.com